GLP-1 Medications: A Weight-Inclusive Perspective on Pros and Cons Over the past few years, GLP-1 receptor agonists (like semaglutide and liraglutide) have captured public attention as game-changers in the treatment of type 2 diabetesand more recently, for weight loss
ACT 2: Tirzepatide (Mounjaro & Zepbound) More Flexibility, Same Discipline Tirzepatide is a dual GIP/GLP-1 receptor agonist, making it pharmacologically distinct from semaglutide
SNAC raises the local pH in the stomach, which leads to higher solubility of semaglutide and protection from degradation by gastric acid
GABA transaminase inhibitors: gabaculine, phenelzine, valproate, vigabatrin, lemon balm ( Melissa officinalis )
Analysis was performed using the Mass Hunter software [26]